A Novel Defined PANoptosis-Related miRNA Signature for Predicting the Prognosis and Immune Characteristics in Clear Cell Renal Cell Carcinoma: A miRNA Signature for the Prognosis of ccRCC

A Novel Defined PANoptosis-Related miRNA Signature for Predicting the Prognosis and Immune Characteristics in Clear Cell Renal Cell Carcinoma: A miRNA Signature for the Prognosis of ccRCC

Clear cell renal cell carcinoma (ccRCC) is one of the most prevalent cancers, and PANoptosis is a distinct, inflammatory-programmed cell death regulated by the PANoptosome. The essential regulators of cancer occurrence and progression are microRNAs (miRNAs). However, the potential function of PANopt...

Full description

Bibliographic Details
Main Authors:	Yanmei Wang, Jia Zhou, Nan Zhang, Yiran Zhu, Yiming Zhong, Zhuo Wang, Hongchuan Jin, Xian Wang
Format:	Article
Language:	English
Published:	MDPI AG 2023-05-01
Series:	International Journal of Molecular Sciences
Subjects:	PANoptosis microRNA clear cell renal cell carcinoma prognostic signature tumor microenvironment
Online Access:	https://www.mdpi.com/1422-0067/24/11/9392

Similar Items

The PANoptosis-related signature indicates the prognosis and tumor immune infiltration features of gliomas
by: Jingjing Song, et al.
Published: (2023-07-01)

Transcription Factor and miRNA Interplays Can Manifest the Survival of ccRCC Patients
by: Shijie Qin, et al.
Published: (2019-10-01)

Analysis of PANoptosis-Related LncRNA-miRNA-mRNA Network Reveals LncRNA SNHG7 Involved in Chemo-Resistance in Colon Adenocarcinoma
by: Jingjing Huang, et al.
Published: (2022-05-01)

PANoptosis-related long non-coding RNA signature to predict the prognosis and immune landscapes of pancreatic adenocarcinoma
by: Qinying Zhao, et al.
Published: (2024-03-01)

Construction and validation of a PANoptosis-related lncRNA signature for predicting prognosis and targeted drug response in thyroid cancer
by: Ruowen Li, et al.
Published: (2023-09-01)

Identification of AKI signatures and classification patterns in ccRCC based on machine learning
by: Li Wang, et al.
Published: (2023-05-01)

Identification of PANoptosis-relevant subgroups to evaluate the prognosis and immune landscape of patients with liver hepatocellular carcinoma
by: Zhengwei Zhang, et al.
Published: (2023-05-01)

Comprehensive Analysis of PANoptosis-Related Gene Signature of Ulcerative Colitis
by: Jun-Meng Wang, et al.
Published: (2023-12-01)

A PANoptosis pattern to predict prognosis and immunotherapy response in head and neck squamous cell carcinoma
by: Feng Gao, et al.
Published: (2024-03-01)

Integrating PANoptosis insights to enhance breast cancer prognosis and therapeutic decision-making
by: Shu Wang, et al.
Published: (2024-03-01)

Definition and verification of novel metastasis and recurrence related signatures of ccRCC: A multicohort study
by: Aimin Jiang, et al.
Published: (2022-08-01)

Advances in mechanism and regulation of PANoptosis: Prospects in disease treatment
by: Peng Zhu, et al.
Published: (2023-02-01)

Analysis of the role of PANoptosis in seizures via integrated bioinformatics analysis and experimental validation
by: Yueying Liu, et al.
Published: (2024-02-01)

Identification of molecular subtypes based on PANoptosis-related genes and construction of a signature for predicting the prognosis and response to immunotherapy response in hepatocellular carcinoma
by: Jinfeng Zhu, et al.
Published: (2023-08-01)

Construction of PANoptosis signature: Novel target discovery for prostate cancer immunotherapy
by: Xianyanling Yi, et al.
Published: (2023-09-01)

Integrated mRNA and miRNA Transcriptomic Analyses Reveals Divergent Mechanisms of Sunitinib Resistance in Clear Cell Renal Cell Carcinoma (ccRCC)
by: María Armesto, et al.
Published: (2021-08-01)

PANoptosis: A Cell Death Characterized by Pyroptosis, Apoptosis, and Necroptosis
by: Shi C, et al.
Published: (2023-04-01)

PANoptosis-based molecular clustering and prognostic signature predicts patient survival and immune landscape in colon cancer
by: Xu Wang, et al.
Published: (2022-09-01)

From pyroptosis, apoptosis and necroptosis to PANoptosis: A mechanistic compendium of programmed cell death pathways
by: Yaqiu Wang, et al.
Published: (2021-01-01)

PANoptosis in cancer, the triangle of cell death
by: Hantao Cai, et al.
Published: (2023-12-01)

Identification of PANoptosis-related signature reveals immune infiltration characteristics and immunotherapy responses for renal cell carcinoma
by: Yan Xu, et al.
Published: (2024-03-01)

Predicting Prognosis and Immunotherapy Response in Multiple Cancers Based on the Association of PANoptosis-Related Genes with Tumor Heterogeneity
by: Yunhan Wang, et al.
Published: (2023-10-01)

A miRNA signature for defining aggressive phenotype and prognosis in gliomas.
by: Raffaela Barbano, et al.
Published: (2014-01-01)

Integrated analysis of single-cell RNA-seq and chipset data unravels PANoptosis-related genes in sepsis
by: Wei Dai, et al.
Published: (2024-01-01)

miRNA Signature in Early-stage Mycosis Fungoides
by: Sissel T. Sørensen, et al.
Published: (2022-10-01)

Corrigendum: Integrated analysis of single-cell RNA-seq and chipset data unravels PANoptosis-related genes in sepsis
by: Wei Dai, et al.
Published: (2024-04-01)

Identification of key genes of the ccRCC subtype with poor prognosis
by: Grigory Andreevich Puzanov
Published: (2022-08-01)

Prognosis of clear cell renal cell carcinoma (ccRCC) based on a six-lncRNA-based risk score: an investigation based on RNA-sequencing data
by: Jiang-hui Zeng, et al.
Published: (2019-08-01)

CD44 Is Associated with Poor Prognosis of ccRCC and Facilitates ccRCC Cell Migration and Invasion through HAS1/MMP9
by: Tan Du, et al.
Published: (2023-07-01)

The emerging role of PANoptosis in cancer treatment
by: Yongai Xiong
Published: (2023-12-01)

Identification of a 3-miRNA Signature Associated With the Prediction of Prognosis in Nasopharyngeal Carcinoma
by: Jinhui Zhou, et al.
Published: (2022-01-01)

In-Depth Mapping of the Urinary <i>N</i>-Glycoproteome: Distinct Signatures of ccRCC-related Progression
by: Lucia Santorelli, et al.
Published: (2020-01-01)

ZBP1 Drives IAV-Induced NLRP3 Inflammasome Activation and Lytic Cell Death, PANoptosis, Independent of the Necroptosis Executioner MLKL
by: R. K. Subbarao Malireddi, et al.
Published: (2023-10-01)

A multiomics disease progression signature of low-risk ccRCC
by: Philipp Strauss, et al.
Published: (2022-08-01)

Impact of cellular miRNAs on circulating miRNA biomarker signatures.
by: Radha Duttagupta, et al.
Published: (2011-01-01)

PANoptosis: Mechanism and Role in Pulmonary Diseases
by: Shiyi Chen, et al.
Published: (2023-10-01)

A Pilot Study About the Role of PANoptosis-Based Genes in Atherosclerosis Development
by: Chen H, et al.
Published: (2023-12-01)

Could miRNA Signatures be Useful for Predicting Uterine Sarcoma and Carcinosarcoma Prognosis and Treatment?
by: Laura Gonzalez dos Anjos, et al.
Published: (2018-09-01)

Development of a 21-miRNA Signature Associated With the Prognosis of Patients With Bladder Cancer
by: Xiao-Hong Yin, et al.
Published: (2019-08-01)

Construction of a Necroptosis-Related miRNA Signature for Predicting the Prognosis of Patients With Hepatocellular Carcinoma
by: Tongyu Meng, et al.
Published: (2022-04-01)